Clinical significance of quantitative monitoring and mutational analysis of BCR-ABL1 transcript in Philadelphia chromosome positive B lymphoblastic leukemia.

导出原文传递

翻译打印收藏纠错

作者： Linsheng,Zhang ^[1] ; Ruan T,Ramjit ^[1] ; Charles E,Hill ^[1] ; Martha,Arellano ^[2] ; H Jean,Khoury ^[2] ; Karen P,Mann ^[1]

作者单位： a Department of Pathology and Laboratory Medicine , Emory University , Atlanta, Georgia. ^[1] b Division of Hematology/Oncology, Winship Cancer Institute, Emory University , Atlanta, Georgia. ^[2]

关键词 B Lymphoblastic Leukemia (B-LL)BCR-ABL1 Philadelphia chromosome Tyrosine kinase inhibitor (TKI)

DOI 10.3109/10428194.2014.1003059

PMID 25573206

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览44

Leukemia & lymphoma

2016年57卷2期

364-369页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical significance of quantitative monitoring and mutational analysis of BCR-ABL1 transcript in Philadelphia chromosome positive B lymphoblastic leukemia.

Leukemia & lymphoma

相似文献

Leukemia & lymphoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical significance of quantitative monitoring and mutational analysis of BCR-ABL1 transcript in Philadelphia chromosome positive B lymphoblastic leukemia.

Leukemia & lymphoma

相似文献

Leukemia & lymphoma

相关期刊

检索历史清除